1. Ercu, Maria, Walter, Stephan, Klussmann, Enno. 2023. Mutations in Phosphodiesterase 3A (PDE3A) Cause Hypertension Without Cardiac Damage. In Hypertension (Dallas, Tex. : 1979), 80, 1171-1179. doi:10.1161/HYPERTENSIONAHA.122.19433. https://pubmed.ncbi.nlm.nih.gov/37035914/
2. Lee, Cha Gon, Kang, Kyusik, Yoon, Ra Gyoung, Seo, Ji Young, Park, Jong-Moo. 2019. PDE3A variant associated with hypertension and brachydactyly syndrome in a patient with ischemic stroke caused by spontaneous intracranial artery dissection: A review of the clinical and molecular genetic features. In European journal of medical genetics, 63, 103781. doi:10.1016/j.ejmg.2019.103781. https://pubmed.ncbi.nlm.nih.gov/31589936/
3. Toivanen, Kirsi, Kilpinen, Sami, Ojala, Kalle, Böhling, Tom, Sihto, Harri. 2023. PDE3A Is a Highly Expressed Therapy Target in Myxoid Liposarcoma. In Cancers, 15, . doi:10.3390/cancers15225308. https://pubmed.ncbi.nlm.nih.gov/38001568/
4. Sucharov, Carmen C, Nakano, Stephanie J, Slavov, Dobromir, Taylor, Matthew R G, Bristow, Michael R. . A PDE3A Promoter Polymorphism Regulates cAMP-Induced Transcriptional Activity in Failing Human Myocardium. In Journal of the American College of Cardiology, 73, 1173-1184. doi:10.1016/j.jacc.2018.12.053. https://pubmed.ncbi.nlm.nih.gov/30871701/
5. Feuerstein, P, Cadoret, V, Dalbies-Tran, R, Guérif, F, Royère, D. 2006. [Oocyte-cumulus dialog]. In Gynecologie, obstetrique & fertilite, 34, 793-800. doi:. https://pubmed.ncbi.nlm.nih.gov/16959524/
智鼠故事 
